Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis
Fig 2
Kaplan-Meier curves of (re-)bleeding rates for all patients with comedication (statin, metformin or RASi) or without comedication (A-C). Bar chart of first bleeding rates (D) and variceal rebleeding rates (E) within 2 years after first endoscopic band ligation, grouped by intake vs. non-intake of the respective co-medication of interest. n (total numbers), 1Y (Year 1), 2Y (Year 2), 3Y (Year 3), HR (Hazard-Ratio); 95% CI (95% confidence interval); n.s. (not significant); statistical comparisons were performed by log-rank tests.